Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

$20m-$39.9m

MiroBio signals for $33.1m
University of Oxford-founded autoimmune disease therapy developer MiroBio has launched with support from OSI and GlaxoSmithKline’s SR One.
Elicio aligns itself with Livzon for $33m
Livzon Pharmaceutical Group has been identified as an investor by MIT spinout Elicio Therapeutics, which just completed a series B round that takes its total financing to $63m.
ZielBio reaches $25.1m series A target
Partners HealthCare has co-led a series A round for ZielBio to drive forward the development of a cancer treatment based on research at University of Virginia.
Meissa synthesises $30m series A
Morningside Ventures has led a $30m series A round for Emory University spinout Meissa Vaccines, a current resident in Johnson & Johnsons’ JLabs incubator.
Tulip unfolds series B round
DMG Mori, an existing customer of MIT spinout Tulip, has contributed to a round that closed at $39.5m, alongside Vertex Ventures, NEA and Pitango.
OncoCell celebrates $22.2m series B
Immonogenomics blood test developer OncoCell, a Harvard Medical School spinout, has increased its total funding to $30m.
Keranova carries over funding from Institut Mérieux
Institut Mérieux has returned for a $26.5m round for surgical technology developer Keranova, having previously supported a $4.6m round three and a half years ago.
WaveOptics glides to $39m
IP Group-backed WaveOptics has obtained $13m to bring its series C round to $39m as it looks to scale in its target markets and ramp up production capacity.

Other News

Trucode extricates $34m
Trucode is advancing in vivo gene editing applications for disorders including sickle cell disease that grew from Yale research and has been backed by GV and Kleiner Perkins.
Autodesk applies itself to aPriori's series C round
Autodesk has led a $26.8m series C round for aPriori, a spinout of University of Illinois at Urbana-Champaign.
Ori aligns $20m
MIT-founded robotic interior design developer Ori found support from Sidewalk Labs and Ingka Group as it looks to deliver full robotic interiors in partnership with architects and property developers.
Cogito coaxes $20m out of investors
Sales team-focused voice analytics software developer Cogito, an MIT spinout, attracted investors including Salesforce, New York Life and Goldman Sachs to bring its overall total to $100m.
Yasa fires up $22m
University of Oxford's electric motor spinout Yasa has added $22m from investors including OSI and Parkwalk Advisors to its coffers to help it cope with growing customer demand.
PBG plates up $26m series A1
Harvard spinout Platelet BioGenesis has added $26m in series A1 financing to its coffers thanks to a consortium co-led by Ziff Capital Partners and Qiming Venture Partners USA.

Editor's Picks

Tel Aviv partners with Tata
Tel Aviv University announces $20m commercialisation fund with Tata Industries.
UK graphene research nets $35m backing
Cell Medica raises $26.5m
Invesco Perpetual, the fund manager, and Imperial Innovations, the London Stock Exchange-listed spin-off from Imperial College London, are joined by The Cancer Prevention and Research Institute of Texas and the Wellcome Trust supporting Cell Medica's growth.
Revolymer sticks to AIM in IPO
Revolymer, which makes chewing gum that is easier to remove from streets and pavements, was backed by the Setsquared Partnership, a joint venture capital initiative between Bath, Bristol, Exeter, Southampton and Surrey.
test reg

Login